Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Monitoring Anti Factor Xa level

Each patient will have baseline Anti-Factor Xa assay checked. During the procedure, Anti-Factor Xa assay is checked concurrently with ACT after heparin bolus and infusion.

Trial Locations (1)

02135

St Elizabeth Medical Center, Brighton

All Listed Sponsors
lead

Steward St. Elizabeth's Medical Center of Boston, Inc.

OTHER

NCT03520868 - Heparin Requirements in Patients Undergoing Atrial Fibrillation Ablation on Coumadin vs NOACs | Biotech Hunter | Biotech Hunter